Whitehawk Therapeutics (WHWK) Gross Margin (2021 - 2025)
Whitehawk Therapeutics (WHWK) reported Gross Margin of 89.36% for Q1 2025, up 154.0% year-over-year from 35.18% in Q1 2024, and little changed on a QoQ basis from 89.09% in Q4 2024.
Whitehawk Therapeutics (WHWK) has 5 years of Gross Margin data on file, last reported at 89.36% in Q1 2025.
- Quarterly Gross Margin rose 154.0% year-over-year to 89.36% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 89.36% (up 100.0% YoY) and the FY2025 annual result came in at 89.36%, up 100.0% from the prior year.
- Gross Margin steadied at 89.36% in Q1 2025 per WHWK's latest filing, from 89.09% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q4 2021 and bottomed at 85.35% in Q4 2023.
- The 5-year median for Gross Margin is 89.23% (2024), against an average of 90.05%.
- The widest annual swing landed in 2023, when Gross Margin tumbled 1041 bps; it then jumped 374 bps in 2024.
- Tracing WHWK's Gross Margin over 5 years: stood at 100.0% in 2021, then declined by 4 bps to 95.75% in 2022, then slipped by 11 bps to 85.35% in 2023, then climbed by 4 bps to 89.09% in 2024, then rose by 0 bps to 89.36% in 2025.
- Per Business Quant, the three latest WHWK Gross Margin figures stand at 89.36% (Q1 2025), 89.09% (Q4 2024), and 88.85% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 89.36% |
| Dec 31, 2024 | 89.09% |
| Sep 30, 2024 | 88.85% |
| Jun 30, 2024 | 87.41% |
| Mar 31, 2024 | 87.82% |
| Dec 31, 2023 | 85.35% |
| Sep 30, 2023 | 88.30% |
| Jun 30, 2023 | 89.42% |
| Mar 31, 2023 | 90.98% |
| Dec 31, 2022 | 95.75% |
| Sep 30, 2022 | 86.03% |
| Jun 30, 2022 | 90.08% |
| Mar 31, 2022 | 92.24% |
| Dec 31, 2021 | 100.00% |